Cargando…
Adequacy of the Comprehensive Clinical Evaluation Program : Nerve Agents.
| Clasificación: | Libro Electrónico |
|---|---|
| Autor principal: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Washington :
National Academies Press,
1997.
|
| Colección: | Online access: National Academy of Sciences National Academies Press.
Online access: NCBI NCBI Bookshelf. |
| Temas: | |
| Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Adequacy of the Comprehensive Clinical Evaluation Program
- Copyright
- Contents
- Executive Summary
- Introduction
- The Comprehensive Clinical Evaluation Program
- OVERVIEW
- IMPLEMENTATION
- CCEP: THE INITIAL IOM REPORT
- CCEP: IOM REVIEW CONTINUED
- Testing for and Identifying Health Effects of Exposure to Nerve Agents
- Recommendations
- References
- Appendixes
- Appendix A Recommendations of the Initial CCEP Committee
- 1.) Overall Assessment of the CCEP Goals Procedures
- 2.) General Recommendations for the Implementation of the CCEP
- 2.1.) Referrals of Patients from Phase I to Phase II of the CCEP2.1.1.) Structure and Revise the CCEP Protocol and Logistics to Allow the Majority of Patients to Receive a Final Diagnosis�
- 2.1.2.) Curtail Diagnostic Work-ups in Patients Not Seriously Disabled with Minor Complaints
- 2.1.3.) Require Additional Efforts to Provide More Care at the Primary Care Level
- 2.1.4.) Continue Referral of Subgroups of Patients Whose Illnesses Are Difficult to Diagnose
- 2.2.) Systematic Guidelines for Psychiatric Referrals and Adequacy of Psychiatric Resources
- 2.2.1.) Develop Explicit Guidelines for the Identification of Phase I Patients Who Would Benefit fro ... 2.2.2.) Alert Primary Care Physicians About the High Prevalence of Psychiatric Disorders
- 3.) Specific Observations of and Recommendations for the Implementation of the CCEP
- 3.1.) Analysis and Interpretation of the CCEP Results
- 3.1.1.) Symptoms and Diagnoses in the CCEP Population
- 3.1.1.1.) No Evidence Has Been Found that the DoD Has Been Trying To Avoid Reaching a Single Unifyin ...
- 3.1.1.2.) Signs and Symptoms in Many Patients Can Be Explained by Well Recognized Conditions3.1.1.3.) Provide More Detailed Information on Specific Diagnoses in Future Reports
- 3.1.1.4.) Investigate the Diagnosis in Patients with Disability Processing Actions
- 3.1.1.5.) Don't View CCEP Results as Estimates of the Prevalence of Disability Related to Persian Gu ...
- 3.1.2.) Evidence of a New, Unique Persian Gulf Syndrome
- 3.1.2.1.) There is a Lack of Clinical Evidence of a Unique Persian Gulf Syndrome
- 3.1.2.2.) Share the Entire CCEP Data Set with Qualified Researchers Outside of the DoD3.1.3.) Potential Relationship of Illnesses in CCEP Patients to Service in the Persian Gulf
- 3.1.3.1.) Discuss the Issue of Causality Explicitly and Unambiguously in its Future Reports
- 3.1.3.2.) Determine the Timing of the Onset of Disease
- 3.1.4.) Comparison of the CCEP Population with Other Populations
- 3.1.4.1.) Be Cautious About Comparison with Other Populations
- 3.1.4.2.) It's Difficult to Establish Causal Relationships by Relying on CCEP Data Alone